CollectionsProstate Cancer
IN THE NEWS

Prostate Cancer

NEWS
September 14, 2015 | By Paul Jablow, For The Inquirer
For researchers, physicians - and patients - prostate cancer has always been among the most maddening and elusive of foes. The third-most common cancer in the United States, behind breast and lung cancers, its course is less predictable than either. It can remain dormant in a man's body until he dies decades later from something else. Or it can spread aggressively and kill. The riddle has been how to tell one cancer from another. Now researchers at Thomas Jefferson University and elsewhere think they are coming closer to solving it through increasingly sophisticated genetic studies.
NEWS
June 19, 2015 | By Tirdad Derakhshani, Inquirer Staff Writer
No future for SeanLize? Robin Wright 's ex-, Sean Penn , won't be the next Mr. Theron, after all. Us Weekly says the Crossing Guard director and his latest paramour, Charlize Theron , have parted ways. Penn, 54, and Theron, 39, who have been pals for years, became engaged in December after dating for about a year. In March, Penn told Esquire UK his past failures would not affect his chances with Theron. "You say I've been married twice before, but I've been married under circumstances where I was less informed than I am today," he said.
NEWS
April 19, 2015 | By Marie McCullough, Inquirer Staff Writer
Researchers who study hereditary breast and ovarian cancer call it "the Angelina Jolie Effect. " They reported a sustained global surge in requests for BRCA genetic testing after the actress wrote about her preventive mastectomy two years ago. Last month, she gave another boost to awareness when she wrote about her recent surgery to remove her ovaries. But raising awareness hasn't necessarily lowered barriers, BRCA experts say. People seeking to identify and manage their inherited cancer risk often confront conflicting, confusing medical guidelines, test options, and insurance coverage.
ENTERTAINMENT
February 11, 2015 | By Molly Eichel
TELEVISION HOST, producer and part-time Philly resident Marc Summers revealed on WWMR's Preston and Steve Show yesterday morning that he is a cancer survivor. Summers, best known as the host of Nickelodeon's "Double Dare" and the Food Network's "Unwrapped" (which doesn't even touch on the numerous shows on which he's served as producer), told listeners that he was diagnosed with chronic lymphocytic leukemia five years ago. He was in chemo for two years, yet still went about his daily business, not revealing his diagnosis.
NEWS
February 4, 2015 | By Bonnie L. Cook, Inquirer Staff Writer
John A. Zinn Jr., 98, of Glen Mills, formerly of Folsom, who installed turbines for Westinghouse Corp. across the globe, died Wednesday, Jan. 28, of prostate cancer at his daughter's home in Media. Called "Jack" by friends, Mr. Zinn was a 1935 graduate of Glen-Nor High School in Glenolden. He volunteered for military service early in 1941 and was accepted into the Army Air Corps during what became World War II later that year. His duties included teaching aerial photography at Lowry Field in Denver, Colo., and participating in a radar technology testing program.
NEWS
January 9, 2015 | By Steve and Mia
Q: I'm a 32-year-old woman. I met a guy who on our first date told me had prostate cancer, but that doctors had operated on him and he was now cancer free. We had an OK time and he asked me out again. My friend said I shouldn't go out with him because of his medical history. What do you think?   Mia: Sorry, girlfriend, but you're not giving us enough information. Are you saying you're squeamish just because he had cancer? Or are you concerned about his ability to father children, or even just get and maintain an erection?
NEWS
January 9, 2015 | By Molly Eichel
ON YESTERDAY'S Preston and Steve show, longtime WMMR morning host Steve  Morrison revealed that he had undergone surgery for prostate cancer. Morrison, who missed only three days of work after robotically having his prostate removed, is now cancer-free. "Four or five hours after the surgery, I was walking around," Morrison told me. "The next day I was doing 2 or 3 miles on the treadmill. " Morrison said he decided to go public with his diagnosis because he wanted to raise awareness for the simple tests that could catch prostate cancer in its early stages.
NEWS
December 26, 2014 | By Kevin Riordan, Inquirer Columnist
The handsome woolen topcoat my father wore to Mass on Christmas was gray - his favorite color - and flecked with tiny white threads. They look like snow in some of the photos my younger siblings and I inherited from our mother, the archivist and curator of 39 Burnham St. Thanks to Mom's meticulous scrapbooks and photo albums, I have the opportunity, in this second holiday season without her, to revisit Christmases past. Three months old in the blurry image of my first Dec. 25, I'm cradled by two young parents who lost their first baby and gaze at their second with a love I still can feel.
NEWS
October 9, 2014 | By Bob Fernandez, Inquirer Staff Writer
Michael Milken, the long-retired 1980s junk-bond king and now big-time prostate cancer philanthropist, blew into the Wanamaker's Crystal Tea Room on Tuesday evening for one of the city's bigger and faster-growing charitable events. He jets around the nation to about 100 of these events a year, flying into Philadelphia on Tuesday from Dallas and planning to immediately depart Philadelphia for Washington. "I see light at the end of the tunnel," Milken said of cancer cures, adding that he believed philanthropists like those in Philadelphia had to support young scientists as the federal government has curtailed medical-research funding in recent years.
NEWS
October 8, 2014 | By Marie McCullough, Inquirer Staff Writer
More than a decade after prostate cancer became the economic driver behind proton beam therapy in the U.S., it still isn't clear that men treated with the technology do better than those who get less costly radiation treatments. That's why expert groups have recently advised against insurance coverage of proton therapy for prostate cancer - and why some private plans are refusing to pay for it. The Catch-22 is that this pullback is hampering a clinical trial co-led by the University of Pennsylvania that would finally settle the question of superiority.
« Prev | 1 | 2 | 3 | 4 | 5 | Next »
|
|
|
|
|